Oncotelic collaborates with TechForce Robotics on AI-enabled GMP manufacturing platform

ONCOTELIC THERAPEUTICS INC

ONCOTELIC THERAPEUTICS INC

OTLC

0.00
  • Oncotelic launched an AI-powered GMP manufacturing services platform built with its PDAOAI system under a collaboration with TechForce Robotics.
  • The partnership targets AI-driven workflows with intelligent robotics to support routine GMP operations, digital batch records, documentation, and quality management.
  • Oncotelic plans to showcase the joint platform at the 2026 BIO International Convention in San Diego.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncotelic Therapeutics Inc. published the original content used to generate this news brief on June 18, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.